BusinessAkari Therapeutics Announces Corporate Update with New Positive Clinical Data and a New Pipeline of Tick Derived and Engineered ProteinsBy Nasdaq OMXDec 5, 2016, 12:00 PM UTC
BusinessApellis Reports Positive Interim Results from Phase 1b Clinical Trials of APL-2 in PNHBy Nasdaq OMXDec 2, 2016, 1:00 PM UTC
BusinessApellis to Present Safety and Efficacy Data from Clinical Trials of APL-2 in PNH at December Scientific MeetingsBy Nasdaq OMXNov 21, 2016, 1:00 PM UTC
BusinessAkari Therapeutics to Attend Upcoming Investor Conferences In NovemberBy Nasdaq OMXNov 11, 2016, 12:00 PM UTC
BusinessAchillion Announces Upcoming Presentations of Novel Research Into Complement Biology at the 58th Annual Meeting of the American Society of HematologyBy Nasdaq OMXNov 3, 2016, 1:01 PM UTC
BusinessAchillion Reports Third Quarter 2016 Financial Results And Provides Update On Clinical ProgramsBy Nasdaq OMXNov 3, 2016, 1:00 PM UTC
BusinessAkari Therapeutics to Present Abstract on Potential Once Weekly PAS-Coversin at the 58th Annual Meeting of the American Society of HematologyBy Nasdaq OMXNov 3, 2016, 12:01 PM UTC
BusinessAkari Therapeutics to Present at Upcoming Investor Conferences on September 27 and 28 in New York CityBy Nasdaq OMXSep 16, 2016, 4:18 PM UTC
